|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and Due from Banks | ||||||||||||||||||||
| Federal Funds Sold and Other Short-term Investments | ||||||||||||||||||||
| Cash and Cash Equivalents | ||||||||||||||||||||
| Interest-bearing Time Deposits with Banks | ||||||||||||||||||||
| Securities Available-for-Sale, at Fair Value (Amortized Cost $1,892,688 for June 30, 2026; Amortized Cost $1,865,732 for December 31, 2025; No Allowance for Credit Losses) | ||||||||||||||||||||
| Other Investments | ||||||||||||||||||||
| Loans Held-for-Sale, at Fair Value | ||||||||||||||||||||
| Loans | ||||||||||||||||||||
| Less: Unearned Income | ||||||||||||||||||||
| Allowance for Credit Losses | ||||||||||||||||||||
| Loans, Net | ||||||||||||||||||||
| Stock in FHLB of Indianapolis and Other Restricted Stock, at Cost | ||||||||||||||||||||
| Premises, Furniture and Equipment, Net | ||||||||||||||||||||
| Other Real Estate | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible Assets | ||||||||||||||||||||
| Company Owned Life Insurance | ||||||||||||||||||||
| Accrued Interest Receivable and Other Assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Non-interest-bearing Demand Deposits | ||||||||||||||||||||
| Interest-bearing Demand, Savings, and Money Market Accounts | ||||||||||||||||||||
| Time Deposits | ||||||||||||||||||||
| Total Deposits | ||||||||||||||||||||
| FHLB Advances and Other Borrowings | ||||||||||||||||||||
| Accrued Interest Payable and Other Liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Common Stock, no par value, $1 stated value; 45,000,000 shares authorized | ||||||||||||||||||||
| Additional Paid-in Capital | ||||||||||||||||||||
| Retained Earnings | ||||||||||||||||||||
| Accumulated Other Comprehensive Income (Loss) | ||||||||||||||||||||
| TOTAL SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| End of period shares issued (in shares) | ||||||||||||||||||||
| End of period shares outstanding (in shares) |
Loading...
